Some studies have shown that biphasic expression of PGC1α was observed in cancer biopsies or cells of breast cancer [171,172,173,174], melanoma [175,176,177], colon cancer [169,178], and ovarian cancer [179,180,181]. Here, PPARGC1A is linked to breast carcinoma.